US Patent Issued to MARENGO THERAPEUTICS on April 29 for "Anti-TCR antibody molecules and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,477, issued on April 29, was assigned to MARENGO THERAPEUTICS INC. (Cambridge, Mass.).

"Anti-TCR antibody molecules and uses thereof" was invented by Seng-Lai Tan (Sudbury, Mass.), Brian Edward Vash (Cambridge, Mass.), Jonathan Hsu (Waltham, Mass.), Dilini Charmain Gunasekera (Cambridge, Mass.), Sangeetha Sagar Palakurthi (East Walpole, Mass.) and Andreas Loew (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides antibody molecules that bind to TCR VBeta regions and multispecific molecules comprising said antibody molecules. Additionally, disclosed are nucleic acids encoding the same, methods of producing the aforesaid molecu...